
Beacon Biosignals is an AI-driven neurotechnology company focused on accelerating drug development for neurological and psychiatric conditions. Their end-to-end platform utilizes FDA-cleared EEG…

Beacon Biosignals is an AI-driven neurotechnology company focused on accelerating drug development for neurological and psychiatric conditions. Their end-to-end platform utilizes FDA-cleared EEG…
What they do: AI-driven neurotechnology: FDA-cleared EEG headbands, cloud datastore, and analytics for biomarkers and clinical-trial support
Founded: 2019
Headquarters: Boston (evidence indicates Boston-based)
Recent financing: Series B upsized to over $97M; cumulative funding reported >$132M
Neurological, psychiatric, and sleep disorders; translational research and clinical-trial biomarker development
2019
Software Development
$86,000,000
Announced $86M Series B (later upsized)
over $97,000,000
Upsized Series B bringing the round to over $97M and cumulative funding to over $132M
General Catalyst listed as lead investor on an earlier round (Series A referenced in records)
“Syndicate includes Innoviva, GV (Google Ventures), S32 (Sanofi Ventures), Catalio Capital Management, General Catalyst, Logos Capital, Casdin Capital, and others”
Beacon Dx is on a mission to transform clinical diagnostics for sleep and brain health. We are building the leading home-based platform for precision diagnostics, combining EEG and cardiopulmonary signals to deliver comprehensive, reimbursable assessments for sleep and central nervous system disorders. Our solution integrates multi-channel physiological data—including airflow, respiratory effort, oxygen saturation, and brain activity—into a single streamlined workflow powered by AI-enabled analytics. With a dedication to patient experience and a foundation in FDA 510(k)-cleared technology, Beacon Dx enables high-quality diagnostics at scale. We are redefining how patients are evaluated and managed for conditions that affect brain and sleep physiology—bringing clinical-grade insights directly to the home.
The National Director, Clinical Excellence and Enablement builds and leads the clinical enablement and adoption engine that accelerates customer onboarding, standardizes workflows, increases utilization, and improves retention. This role partners closely with Sales, Operations, and Product to reduce adoption friction, shorten sales cycles, and translate clinical performance into measurable commercial outcomes across enterprise and multi site customers.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week
| Company |
|---|
Beacon's robust asynchronous work practices ensure a first-class remote work experience, but we also have in-person office hubs available located in Boston, New York, Cleveland, and Paris.
What Success Looks Like
What You Will Bring
Preferred Qualifications
The base salary range for this role is determined based on past experience, specific skills and qualifications. The base salary is one component of the total compensation package, which includes equity, PTO and other benefits.
At Beacon, we've found that cultural and scientific impact is driven most by those that lead by example. As such, we're always seeking new contributors whose work demonstrates an avid curiosity, a bias towards simplicity, an eye for composability, a self-service mindset, and - most of all - a deep empathy towards colleagues, stakeholders, users, and patients. We believe a diverse team builds more robust systems and achieves higher impact.